Kodiak Sciences (KOD) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

KOD Kodiak Sciences

Watchlist

3.000
+0.120+4.17%

Close Oct 16 16:00 ET

3.000
0.0000.00%

Post 17:16 ET

157.84MMarket Cap-795P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Kodiak Sciences to Present at Innovate Retina 2024
PR NewswireOct 14 17:35 ET
Kodiak Sciences Participates in a Conference Call With JPMorgan
TipRanksSep 30 12:15 ET
Evercore Initiates Kodiak Sciences(KOD.US) With Buy Rating
Moomoo NewsSep 25 08:31 ET · Ratings
Barclays Releases a Sell Rating on Kodiak Sciences (KOD)
TipRanksSep 25 05:05 ET · Ratings
Goldman Sachs Maintains Kodiak Sciences(KOD.US) With Sell Rating, Maintains Target Price $2
Moomoo NewsSep 24 16:31 ET · Ratings
H.C. Wainwright Maintains Kodiak Sciences(KOD.US) With Hold Rating, Maintains Target Price $3
Moomoo NewsSep 24 06:31 ET · Ratings

Comments

Meltyy

May 16 01:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

Jaguar8

May 13 19:31

$Kodiak Sciences (KOD.US)$
NEWS
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy

Jaguar8

May 2 15:39

$Kodiak Sciences (KOD.US)$
NEWS
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform

JuliaBiswas

Feb 5 04:12

Who is the winner today, after the poditive data announced on 03 Feb
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$

JuliaBiswas

Feb 4 22:11

$Kodiak Sciences (KOD.US)$ announced first time results of KSI-501 ABC Phase 1 study. The data outlined safety and biocativity of KSI-501, along with high binding affinity and bioactivity against VEGF and IL-6.

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

KOD Kodiak Sciences

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target